Rights and permissions
About this article
Cite this article
Eptifibatide cost effective for acute coronary disorders. Pharmacoecon. Outcomes News 351, 9 (2002). https://doi.org/10.1007/BF03278734
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03278734